These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21953616)

  • 41. A hierarchical spectral clustering and nonlinear dimensionality reduction scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS).
    Tiwari P; Rosen M; Madabhushi A
    Med Phys; 2009 Sep; 36(9):3927-39. PubMed ID: 19810465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A 3D trajectory for undersampling k-space in MRSI applications.
    Uribe S; Guesalaga A; Mir R; Guarini M; Irarrázaval P
    Magn Reson Imaging; 2007 Apr; 25(3):350-8. PubMed ID: 17371724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma.
    Averna TA; Kline EE; Smith AY; Sillerud LO
    J Urol; 2005 Feb; 173(2):433-8. PubMed ID: 15643195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exponential convergence rate (the spectral convergence) of the fast Padé transform for exact quantification in magnetic resonance spectroscopy.
    Belkić D
    Phys Med Biol; 2006 Dec; 51(24):6483-512. PubMed ID: 17148831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
    Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
    Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anatomic segmentation improves prostate cancer detection with artificial neural networks analysis of 1H magnetic resonance spectroscopic imaging.
    Matulewicz L; Jansen JF; Bokacheva L; Vargas HA; Akin O; Fine SW; Shukla-Dave A; Eastham JA; Hricak H; Koutcher JA; Zakian KL
    J Magn Reson Imaging; 2014 Dec; 40(6):1414-21. PubMed ID: 24243554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. (1)H MR spectroscopic imaging of the prostate at 7T using spectral-spatial pulses.
    Lagemaat MW; Breukels V; Vos EK; Kerr AB; van Uden MJ; Orzada S; Bitz AK; Maas MC; Scheenen TW
    Magn Reson Med; 2016 Mar; 75(3):933-45. PubMed ID: 25943445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Automated quantification of human brain metabolites by artificial neural network analysis from in vivo single-voxel 1H NMR spectra.
    Kaartinen J; Mierisová S; Oja JM; Usenius JP; Kauppinen RA; Hiltunen Y
    J Magn Reson; 1998 Sep; 134(1):176-9. PubMed ID: 9740747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantification of human brain metabolites from in vivo 1H NMR magnitude spectra using automated artificial neural network analysis.
    Hiltunen Y; Kaartinen J; Pulkkinen J; Häkkinen AM; Lundbom N; Kauppinen RA
    J Magn Reson; 2002 Jan; 154(1):1-5. PubMed ID: 11820820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elliptical magnetic resonance spectroscopic imaging with GRAPPA for imaging brain tumors at 3 T.
    Banerjee S; Ozturk-Isik E; Nelson SJ; Majumdar S
    Magn Reson Imaging; 2009 Dec; 27(10):1319-25. PubMed ID: 19577396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absolute choline tissue concentration mapping for prostate cancer localization and characterization using 3D
    Tayari N; Wright AJ; Heerschap A
    Magn Reson Med; 2022 Feb; 87(2):561-573. PubMed ID: 34554604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N; Morales H; Modrego PJ; Pina MA
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): pattern changes from inflammation to prostate cancer.
    Sciarra A; Panebianco V; Ciccariello M; Salciccia S; Lisi D; Osimani M; Alfarone A; Gentilucci A; Parente U; Passariello R; Gentile V
    Cancer Invest; 2010 May; 28(4):424-32. PubMed ID: 20073578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Post-acquisition water-signal removal in 3D water-unsuppressed
    Stamatelatou A; Sima DM; van Huffel S; van Asten JJA; Heerschap A; Scheenen TWJ
    Magn Reson Med; 2023 May; 89(5):1741-1753. PubMed ID: 36572967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
    Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
    NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantification of MRS data in the frequency domain using a wavelet filter, an approximated Voigt lineshape model and prior knowledge.
    Gillies P; Marshall I; Asplund M; Winkler P; Higinbotham J
    NMR Biomed; 2006 Aug; 19(5):617-26. PubMed ID: 16927392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo prostate magnetic resonance spectroscopic imaging using two-dimensional J-resolved PRESS at 3 T.
    Kim DH; Margolis D; Xing L; Daniel B; Spielman D
    Magn Reson Med; 2005 May; 53(5):1177-82. PubMed ID: 15844143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 1H magnetic resonance spectroscopy of prostate cancer: biomarkers for tumor characterization.
    Zakian KL; Shukla-Dave A; Ackerstaff E; Hricak H; Koutcher JA
    Cancer Biomark; 2008; 4(4-5):263-76. PubMed ID: 18957715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Automated estimation of tumor probability in prostate magnetic resonance spectroscopic imaging: pattern recognition vs quantification.
    Kelm BM; Menze BH; Zechmann CM; Baudendistel KT; Hamprecht FA
    Magn Reson Med; 2007 Jan; 57(1):150-9. PubMed ID: 17191229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.